Should combination LABA/ICS inhalers be first line in mild asthma?

Blog entry written on: Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane Systematic Review, (bmjebm-2021-111764)’ Authors: Iain Crossingham, Sally Turner, Sanjay Ramakrishnan, Anastasia Fries, Matthew Gowell, Farhat Yasmin, Rebekah Richardson, Philip Webb, Emily O’Boyle,Timothy Stopford Christopher Hinks. Blog entry written on: Combination fixed‐dose beta agonist […]

Read More…

On “clinical vulnerability” during COVID-19

Blog entry written on: ‘Asthma and COVID-19: a review of evidence on risks and management considerations’ (bmjebm-2020-111506) Authors: Jamie Hartmann-Boyce, James Gunnell, Jonny Drake, Afolarin Otunla, Jana Suklan, Ella Schofield, Jade Kinton, Matt Inada-Kim, F D Richard Hobbs, Paddy Dennison Not all reasonable assumptions prove true. At the beginning of the COVID-19 pandemic all people […]

Read More…